Virbac SA (EPA: VIRP)
France
· Delayed Price · Currency is EUR 388.50
-3.50 (-0.89%)
Sep 25, 2024, 5:35 PM CET
Virbac Revenue
Virbac had revenue of 702.93M EUR in the half year ending June 30, 2024, with 14.05% growth. This brings the company's revenue in the last twelve months to 1.34B, up 10.66% year-over-year. In the year 2023, Virbac had annual revenue of 1.25B with 2.53% growth.
Revenue (ttm)
1.34B
Revenue Growth
+10.66%
P/S Ratio
2.45
Revenue / Employee
245.35K
Employees
5,459
Market Cap
3.27B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 1.25B | 30.71M | 2.53% |
| Dec 31, 2022 | 1.22B | 152.22M | 14.31% |
| Dec 31, 2021 | 1.06B | 129.77M | 13.89% |
| Dec 31, 2020 | 934.20M | -4.14M | -0.44% |
| Dec 31, 2019 | 938.34M | 69.41M | 7.99% |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
| Dec 31, 2014 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Sanofi | 47.08B |
| EssilorLuxottica Société anonyme | 25.83B |
| Sartorius Stedim Biotech S.A. | 2.75B |
| bioMérieux S.A. | 3.81B |
| Eurofins Scientific SE | 6.72B |
| Ipsen S.A. | 3.44B |
| Ramsay Générale de Santé SA | 5.01B |
| Vetoquinol SA | 537.47M |
Virbac News
- 10 days ago - Virbac SA (VRBCF) Q2 2024 Earnings Call Transcript - Seeking Alpha